VOYAGER THERAPEUTICS INC (VYGR) Forecast, Price Target & Analyst Ratings

NASDAQ:VYGR • US92915B1061

Current stock price

3.96 USD
-0.01 (-0.25%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VOYAGER THERAPEUTICS INC (VYGR).

Forecast Snapshot

Consensus Price Target

Price Target
$17.17
+ 333.59% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.54
Revenue Estimate
8.331M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
87.78%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$17.17
Upside
+ 333.59%
From current price of $3.96 to mean target of $17.17, Based on 18 analyst forecasts
Low
$8.08
Median
$18.36
High
$26.25

Price Target Revisions

1 Month
12.22%
3 Months
12.22%

Price Target Summary

18 Wall Street analysts provided a forecast for the next 12 months for VYGR. The average price target is 17.17 USD. This implies a price increase of 333.59% is expected in the next year compared to the current price of 3.96.
The average price target has been revised upward by 12.22% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

VYGR Current Analyst RatingVYGR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

VYGR Historical Analyst RatingsVYGR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
87.78%
VYGR was analyzed by 18 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about VYGR.
In the previous month the buy percentage consensus was at a similar level.
VYGR was analyzed by 18 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-17HC Wainwright & Co.Reiterate Buy -> Buy
2025-11-12HC Wainwright & Co.Maintains Buy -> Buy
2025-09-15HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-07WedbushMaintains Outperform -> Outperform
2025-04-08HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-13Canaccord GenuityMaintains Buy -> Buy
2025-03-13HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-12Cantor FitzgeraldReiterate Overweight -> Overweight
2025-03-12WedbushReiterate Outperform -> Outperform
2025-03-12Wells FargoMaintains Overweight -> Overweight
2025-03-03HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-27HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-10Cantor FitzgeraldInitiate Overweight
2024-12-02CitigroupInitiate Buy
2024-11-14Canaccord GenuityMaintains Buy -> Buy
2024-11-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-24HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-16Leerink PartnersInitiate Outperform
2024-08-20HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-07WedbushMaintains Neutral -> Neutral
2024-07-31HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-15OppenheimerMaintains Outperform -> Outperform
2024-05-14WedbushMaintains Neutral -> Neutral
2024-03-26GuggenheimInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.54
Revenue Estimate
8.331M
Revenue Q2Q
28.70%
EPS Q2Q
-2.56%
Number of Analysts
13

Next Earnings Revisions

Revenue (1 Month)
-12.88%
Revenue (3 Months)
-12.88%
EPS (1 Month)
-8.98%
EPS (3 Months)
-8.98%

Next Earnings Summary

VYGR is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.54 USD and the consensus revenue estimate is 8.33M USD.
The next earnings revenue estimate has been revised downward by 12.88% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
VYGR revenue by date.VYGR revenue by date.
250.008M
511.27%		80.001M
-68.00%		40.374M
-49.53%		54.116M
34.04%		58.404M
7.92%		76.925M
31.71%		59.874M
-22.17%		67.575M
12.86%		225.73M
234.04%		457.42M
102.64%		650.89M
42.30%
EBITDA
YoY % growth
VYGR ebitda by date.VYGR ebitda by date.
126.455M
383.47%		-75.756M
-159.91%		-127.784M
-68.68%		-117M
8.44%		-107.344M
8.25%		-123.981M
-15.50%		-126.48M
-2.02%		-136.017M
-7.54%		79.152M
158.19%		535.81M
576.94%		834.56M
55.76%
EBIT
YoY % growth
VYGR ebit by date.VYGR ebit by date.
122.014M
340.19%		-80.487M
-165.97%		-131.844M
-63.81%		-127.395M
3.37%		-136.582M
-7.21%		-145.35M
-6.42%		-175.925M
-21.04%		-192.077M
-9.18%		-130.672M
31.97%		16.559M
112.67%		163.84M
889.43%
Operating Margin
VYGR operating margin by date.VYGR operating margin by date.
48.80%-100.61%-326.56%-235.41%-233.86%-188.95%-293.83%-284.24%-57.89%3.62%25.17%
EPS
YoY % growth
VYGR eps by date.VYGR eps by date.
3.09
353.28%		-1.13
-136.57%		-2.03
-79.65%		-1.63
19.54%		-1.43
12.66%		-1.33
6.55%		-1.58
-18.20%		-1.67
-5.72%		0.03
101.53%		1.86
7,180.00%		3.05
64.56%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.54
-2.56%		-0.52
8.25%		-0.46
1.73%		-0.42
8.42%		-0.46
15.18%		-0.47
9.89%		-0.48
-2.91%		-0.48
-13.80%
Revenue
Q2Q % growth		8.331M
28.70%		10.106M
94.35%		14.822M
10.90%		14.327M
-6.58%		8.894M
6.76%		8.894M
-11.99%		8.894M
-39.99%		9.2M
-35.79%
EBITDA
Q2Q % growth		-29.04M
13.77%		-29.706M
14.01%		-29.487M
-6.90%		-28.759M
-11.16%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-36.282M
-4.58%		-35.086M
4.20%		-31.506M
-2.98%		-32.08M
-7.17%		-41.168M
-13.47%		-42.181M
-20.22%		-43.229M
-37.21%		-44.44M
-38.53%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VYGR Yearly Revenue VS EstimatesVYGR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M
VYGR Yearly EPS VS EstimatesVYGR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -5 -10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
10.34%
EPS Next 5 Year
3.35%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
28.51%
Revenue Next 5 Year
13.27%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
3.11%
EBIT Next 5 Year
0.17%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

VOYAGER THERAPEUTICS INC / VYGR Forecast FAQ

What is the price target for VYGR stock?

18 analysts have analysed VYGR and the average price target is 17.17 USD. This implies a price increase of 333.59% is expected in the next year compared to the current price of 3.96.

When does VOYAGER THERAPEUTICS INC (VYGR) report earnings?

VOYAGER THERAPEUTICS INC (VYGR) will report earnings on 2026-05-04.

What are the consensus estimates for VOYAGER THERAPEUTICS INC (VYGR) next earnings?

The consensus EPS estimate for the next earnings of VOYAGER THERAPEUTICS INC (VYGR) is -0.54 USD and the consensus revenue estimate is 8.33M USD.

What is the expected long term growth rate for VOYAGER THERAPEUTICS INC (VYGR)?

The expected long term growth rate for VOYAGER THERAPEUTICS INC (VYGR) is 28.51%.